Novel Oral miR-124 Enhancer Improves Remission in Refractory UC

(MedPage Today) — PHOENIX — A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for patients with moderately to severely active ulcerative colitis (UC) who had failed multiple prior therapies…